Food and Drug Administration

Endocrinologic and Metabolic Drugs Advisory Committee

September 8, 2004


Food and Drug Laws, Dr. Eric Colman, MD, FDA (HTM) (PPT)

The Epidemiology of Overweight and Obesity, Dr. Katherine Flegal, PhD, CDC (HTM) (PPT)

Patterns of Prescription Weight-Loss Drug Use, Dr. Laura Governale, Pharm D, MBA (PPT)

Obesity Drugs: Current Status and Future Potential, Dr. Richard Atkinson, MD (HTM) (PPT)

FDA 2004: Revisiting the 1986 Obesity Drug Guidance, Dr. David Orloff, MD, FDA (HTM) (PPT)

Questions (HTM) (PPT)